Drug intelligence / Profile preview

Gastrogel

Development stage
Unknown
Lead developer
Arrotex
Modality
Small Molecules
Administration
Oral
01

Overview

Gastrogel is an over-the-counter oral liquid antacid combination formulation containing dried aluminium hydroxide gel, magnesium trisilicate, and magnesium hydroxide. It is manufactured by Aspen Pharma and distributed by Arrotex Pharmaceuticals (and previously Viatris) in Australia. Gastrogel works by chemically neutralizing gastric acid in the stomach, thereby raising gastric pH to provide rapid relief from symptoms of dyspepsia, indigestion, heartburn, epigastric pain, and upset stomach. In the Royal Melbourne Hospital's COOLAID clinical trial, Gastrogel monotherapy was evaluated against combinations of Gastrogel with oral lidocaine (viscous or solution) for the treatment of acute epigastric pain and dyspepsia in the emergency department. The trial demonstrated that antacid monotherapy with Gastrogel was equally effective in pain relief compared to the lidocaine combinations, while being significantly more palatable and better tolerated by patients.

Brand names
Gastrogel

Beyond the preview

Go deeper on Gastrogel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gastrogel.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call